These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18270714)

  • 1. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions.
    Veltman J; Stoutjesdijk M; Mann R; Huisman HJ; Barentsz JO; Blickman JG; Boetes C
    Eur Radiol; 2008 Jun; 18(6):1123-33. PubMed ID: 18270714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis.
    El Khouli RH; Macura KJ; Kamel IR; Jacobs MA; Bluemke DA
    AJR Am J Roentgenol; 2011 Dec; 197(6):1498-505. PubMed ID: 22109308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
    Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
    J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
    Abe H; Mori N; Tsuchiya K; Schacht DV; Pineda FD; Jiang Y; Karczmar GS
    AJR Am J Roentgenol; 2016 Nov; 207(5):1159-1166. PubMed ID: 27532897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer aided analysis of breast MRI enhancement kinetics using mean shift clustering and multifeature iterative region of interest selection.
    Stoutjesdijk MJ; Zijp M; Boetes C; Karssemeijer N; Barentsz JO; Huisman H
    J Magn Reson Imaging; 2012 Nov; 36(5):1104-12. PubMed ID: 22786883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving malignancy prediction in breast lesions with the combination of apparent diffusion coefficient and dynamic contrast-enhanced kinetic descriptors.
    Nogueira L; Brandão S; Matos E; Gouveia Nunes R; Ferreira HA; Loureiro J; Ramos I
    Clin Radiol; 2015 Sep; 70(9):1016-25. PubMed ID: 26135541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
    Goto M; Sakai K; Yokota H; Kiba M; Yoshida M; Imai H; Weiland E; Yokota I; Yamada K
    Eur Radiol; 2019 Mar; 29(3):1164-1174. PubMed ID: 30088064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions.
    Mori N; Pineda FD; Tsuchiya K; Mugikura S; Takahashi S; Karczmar GS; Abe H
    AJR Am J Roentgenol; 2018 Oct; 211(4):933-939. PubMed ID: 30063374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging of breast tumors at 3 and 7 T: a comparison.
    Gruber S; Pinker K; Zaric O; Minarikova L; Chmelik M; Baltzer P; Boubela RN; Helbich T; Bogner W; Trattnig S
    Invest Radiol; 2014 May; 49(5):354-62. PubMed ID: 24619208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study.
    Thomassin-Naggara I; Balvay D; Aubert E; Daraï E; Rouzier R; Cuenod CA; Bazot M
    Eur Radiol; 2012 Apr; 22(4):738-45. PubMed ID: 22105841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
    Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
    Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
    Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
    Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.